Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(60.0%)

Phase 4

1(20.0%)

Phase 3

1(20.0%)

5Total

N/A(3)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03474991Phase 3Completed

KIDS-STEP_Betamethasone Therapy in Hospitalised Children With CAP

Role: collaborator

NCT05029414Not ApplicableActive Not Recruiting

EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke

Role: collaborator

NCT04129840Not ApplicableCompleted

Identifying Most Effective Treatment Strategies to Control Arterial Hypertension in Sub-Saharan Africa

Role: collaborator

NCT03452462Not ApplicableCompleted

Electrical Resynchronization and Acute Hemodynamic Effects of Direct His Bundle Pacing Compared to Biventricular Pacing

Role: collaborator

NCT03221959Unknown

Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Descompressive Craniectomy.

Role: collaborator

NCT00818610Phase 4Completed

Monotherapy Versus Bitherapy in Non-severe Hospitalized Community-acquired Pneumonia

Role: lead

NCT00866567Completed

Defects in Opsonophagocytosis in Premature Infants

Role: collaborator

All 7 trials loaded